세계의 생체 흡수성 임플란트 시장 : 산업 분석, 규모, 점유율, 성장, 동향 예측(2024-2033년)

Persistence Market Research has recently released a comprehensive report on the worldwide market for bioabsorbable implants. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

• Bioabsorbable Implants Market Size (2024E): USD 659.3 million
• Projected Market Value (2033F): USD 823.1 million
• Global Market Growth Rate (CAGR 2024 to 2033):2.5%

Bioabsorbable Implants Market - Report Scope:

Bioabsorbable implants, made from biodegradable materials, are designed to gradually break down in the body after fulfilling their intended purpose. These implants eliminate the need for a second surgery to remove them, making them popular in various medical procedures, particularly in orthopedics, cardiovascular surgery, and tissue repair. The market caters to hospitals, specialty clinics, and outpatient surgical centers, offering a range of implant types, including plates, screws, pins, and meshes made from materials like polylactic acid (PLA) and polyglycolic acid (PGA).

Market Growth Drivers:

The global bioabsorbable implants market is driven by several factors, including the increasing demand for minimally invasive surgeries and the growing prevalence of orthopedic and cardiovascular conditions. Advances in material science, such as the development of new polymers and composites that enhance the bioabsorption process, are driving market innovation. The rising geriatric population and the increasing number of sports-related injuries also contribute to the demand for bioabsorbable implants, as these patients benefit from implants that reduce long-term complications and improve recovery times.

Market Restraints:

Despite promising growth prospects, the bioabsorbable implants market faces challenges related to high manufacturing costs and regulatory hurdles. The rigorous approval processes for bioabsorbable materials, especially in regions with stringent healthcare regulations, can delay market entry and increase development costs. Additionally, the limited availability of clinical data demonstrating long-term outcomes of bioabsorbable implants compared to traditional metal implants poses a challenge for market penetration.

Market Opportunities:

The bioabsorbable implants market presents significant growth opportunities through technological advancements and the expansion of their application areas. Research into new bioabsorbable materials with enhanced mechanical properties and controlled degradation rates is expected to drive future market growth. Furthermore, the increasing use of bioabsorbable implants in areas such as maxillofacial surgery and pediatric care, where long-term implantation may pose risks, is creating new avenues for market expansion. Partnerships between medical device manufacturers and healthcare providers will also be crucial in promoting the adoption of bioabsorbable implants.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the bioabsorbable implants market globally?
• Which implant types and medical procedures are driving bioabsorbable implant adoption across different healthcare settings?
• How are technological advancements reshaping the competitive landscape of the bioabsorbable implants market?
• Who are the key players contributing to the bioabsorbable implants market, and what strategies are they employing to maintain market relevance?
• What are the emerging trends and future prospects in the global bioabsorbable implants market?

Competitive Intelligence and Business Strategy:

Leading players in the global bioabsorbable implants market, including Stryker Corporation, Zimmer Biomet, and Johnson & Johnson, focus on innovation and product differentiation to gain a competitive edge. These companies invest in research and development to enhance the performance and safety of bioabsorbable implants, catering to the evolving needs of patients and surgeons. Strategic partnerships and collaborations with healthcare providers and research institutions enable these players to expand their market presence. Additionally, companies are increasingly focusing on clinical trials and obtaining regulatory approvals to bolster product credibility and market acceptance.

Key Companies Profiled:

• Stryker Corporation
• Zimmer Biomet
• Johnson & Johnson
• Smith & Nephew
• Medtronic Plc
• Boston Scientific Corporation
• Bioretec Ltd.
• Orthocell Ltd.
• KLS Martin Group
• DePuy Synthes

Key Segments of Bioabsorbable Implant Market Research

By Product Type :

• Stents
• Biological Meshes
• Fixation Devices

By Material :

• Metallic
• Ceramic
• Polymers

By Application :

• Orthopedic
• Cardiovascular
• By End User :
• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics

By Region :

• North America
• Latin America
• Europe
• East Asia
• South Asia & Oceania
• Middle East & Africa

Table of Contents

1. Executive Summary

• 1.1. Global Market Outlook
• 1.2. Trends
• 1.3. Top Players for Bioabsorbable Implants Market
• 1.4. Analysis and Recommendations

2. Market Overview

• 2.1. Market Coverage / Taxonomy
• 2.2. Market Definition / Scope / Limitations

3. Key Success Factors

• 3.1. Product Adoption / Usage Analysis
• 3.2. Iceberg Analysis
• 3.3. Regulatory Scenario
• 3.4. Reimbursement Scenario
• 3.5. Comparison of Products

4. Global Bioabsorbable Implants Market Demand (in Value or Size in US$ Mn) Analysis 2019-2023 and Forecast, 2024-2033

• 4.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
• 4.2. Current and Future Market Value (US$ Mn) Projections, 2024-2033
  • 4.2.1. Y-o-Y Growth Trend Analysis
  • 4.2.2. Absolute $ Opportunity Analysis

5. Market Background

• 5.1. Macro-Economic Factors
  • 5.1.1. Global GDP Growth Outlook
  • 5.1.2. Global Healthcare Industry Market Outlook
  • 5.1.3. Regulatory Scenario
• 5.2. Forecast Factors - Relevance & Impact
  • 5.2.1. Manufacturers expanding their distribution channel
  • 5.2.2. Alternative Product Availability
  • 5.2.3. Alternative Product Availability
  • 5.2.4. Technology advancements
• 5.3. Value Chain
• 5.4. Market Dynamics
  • 5.4.1. Drivers
  • 5.4.2. Restraints
  • 5.4.3. Opportunity Analysis

6. Global Bioabsorbable Implants Market Analysis 2019-2023 and Forecast 2024-2033, by Product Type

• 6.1. Introduction / Key Findings
• 6.2. Historical Market Size (US$ Mn) Analysis by Product Type, 2019-2023
• 6.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Product Type, 2024-2033
  • 6.3.1. Stents
    • 6.3.1.1. Coronary Artery Stents
    • 6.3.1.2. Peripheral Artery Stents
    • 6.3.1.3. Non vascular Stents
      • 6.3.1.3.1. Esophageal Stents
      • 6.3.1.3.2. Biliary stents
  • 6.3.2. Biological Meshes
  • 6.3.3. Fixation Devices
• 6.4. Market Attractiveness Analysis by Product Type

7. Global Bioabsorbable Implants Market Analysis 2019-2023 and Forecast 2024-2033, by Material Type

• 7.1. Introduction / Key Findings
• 7.2. Historical Market Size (US$ Mn) Analysis by Material Type, 2019-2023
• 7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Material Type, 2024-2033
  • 7.3.1. Metallic
  • 7.3.2. Ceramics
  • 7.3.3. Polymers
    • 7.3.3.1. PGA (Polyglycolide)
    • 7.3.3.2. PLA (Polylactide)
    • 7.3.3.3. Co-polymers
• 7.4. Market Attractiveness Analysis by Material Type

8. Global Bioabsorbable Implants Market Analysis 2019-2023 and Forecast 2024-2033, by Application

• 8.1. Introduction / Key Findings
• 8.2. Historical Market Size (US$ Mn) Analysis by Application, 2019-2023
• 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Application, 2024-2033
  • 8.3.1. Cardiovascular
  • 8.3.2. Orthopedics
  • 8.3.3. Cosmetic Surgery
  • 8.3.4. General Surgery
  • 8.3.5. Cranial
  • 8.3.6. Others Market Attractiveness Analysis by Application

9. Global Bioabsorbable Implants Market Analysis 2019-2023 and Forecast 2024-2033, by End User

• 9.1. Introduction / Key Findings
• 9.2. Historical Market Size (US$ Mn) Analysis by End User, 2019-2023
• 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by End User, 2024-2033
  • 9.3.1. Hospitals
  • 9.3.2. Specialty Clinics
  • 9.3.3. Ambulatory Surgical Centers
• 9.4. Market Attractiveness Analysis by End User

10. Global Bioabsorbable Implants Market Analysis 2019-2023 and Forecast 2024-2033, by Region

• 10.1. Introduction
• 10.2. Historical Market Size (US$ Mn) Analysis by Region, 2019-2023
• 10.3. Current Market Size (US$ Mn) Analysis and Forecast by Region, 2024-2033
  • 10.3.1. North America
  • 10.3.2. Latin America
  • 10.3.3. Europe
  • 10.3.4. Middle East and Africa (MEA)
  • 10.3.5. East Asia
  • 10.3.6. South Asia
  • 10.3.7. Oceania
• 10.4. Market Attractiveness Analysis by Region

11. North America Bioabsorbable Implants Market Analysis 2019-2023 and Forecast 2024-2033

• 11.1. Introduction
• 11.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
• 11.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2033
  • 11.3.1. By Country
    • 11.3.1.1. U.S.
    • 11.3.1.2. Canada
  • 11.3.2. By Product Type
  • 11.3.3. By Material Type
  • 11.3.4. By End User
• 11.4. Market Attractiveness Analysis
  • 11.4.1. By Country
  • 11.4.2. By Product Type
  • 11.4.3. By Material Type
  • 11.4.4. By End User
• 11.5. Key Market Participants - Intensity Mapping
• 11.6. Drivers and Restraints - Impact Analysis

12. Latin America Bioabsorbable Stents Market Analysis 2019-2023 and Forecast 2024-2033

• 12.1. Introduction
• 12.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
• 12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2033
  • 12.3.1. By Country
    • 12.3.1.1. Brazil
    • 12.3.1.2. Mexico
    • 12.3.1.3. Rest of Latin America
  • 12.3.2. By Product Type
  • 12.3.3. By Material Type
  • 12.3.4. By End User
• 12.4. Market Attractiveness Analysis
  • 12.4.1. By Country
  • 12.4.2. By Product Type
  • 12.4.3. By Material Type
  • 12.4.4. By End User
• 12.5. Key Market Participants - Intensity Mapping
• 12.6. Drivers and Restraints - Impact Analysis

13. Europe Bioabsorbable Stents Market Analysis 2019-2023 and Forecast 2024-2033

• 13.1. Introduction
• 13.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
• 13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2033
  • 13.3.1. By Country
    • 13.3.1.1. Germany
    • 13.3.1.2. Italy
    • 13.3.1.3. France
    • 13.3.1.4. U.K.
    • 13.3.1.5. Spain
    • 13.3.1.6. Russia
    • 13.3.1.7. Rest of Europe
  • 13.3.2. By Product Type
  • 13.3.3. By Material Type
  • 13.3.4. By End User
• 13.4. Market Attractiveness Analysis
  • 13.4.1. By Country
  • 13.4.2. By Product Type
  • 13.4.3. By Material Type
  • 13.4.4. By End Users
• 13.5. Key Market Participants - Intensity Mapping
• 13.6. Drivers and Restraints - Impact Analysis

14. South Asia Bioabsorbable Stents Market Analysis 2019-2023 and Forecast 2024-2033

• 14.1. Introduction
• 14.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
• 14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2033
  • 14.3.1. By Country
    • 14.3.1.1. India
    • 14.3.1.2. Thailand
    • 14.3.1.3. Indonesia
    • 14.3.1.4. Malaysia
    • 14.3.1.5. Rest of South Asia
  • 14.3.2. By Product Type
  • 14.3.3. By Material Type
  • 14.3.4. By End User
• 14.4. Market Attractiveness Analysis
  • 14.4.1. By Country
  • 14.4.2. By Product Type
  • 14.4.3. By Material Type
  • 14.4.4. By End User
• 14.5. Key Market Participants - Intensity Mapping
• 14.6. Drivers and Restraints - Impact Analysis

15. East Asia Bioabsorbable Stents Market Analysis 2019-2023 and Forecast 2024-2033

• 15.1. Introduction
• 15.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
• 15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2033
  • 15.3.1. By Country
    • 15.3.1.1. China
    • 15.3.1.2. Japan
    • 15.3.1.3. South Korea
  • 15.3.2. By Product Type
  • 15.3.3. By Material Type
  • 15.3.4. By End User
• 15.4. Market Attractiveness Analysis
  • 15.4.1. By Country
  • 15.4.2. By Product Type
  • 15.4.3. By Material Type
  • 15.4.4. By End User
• 15.5. Key Market Participants - Intensity Mapping
• 15.6. Drivers and Restraints - Impact Analysis

16. Oceania Bioabsorbable Stents Market Analysis 2019-2023 and Forecast 2024-2033

• 16.1. Introduction
• 16.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
• 16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2033
  • 16.3.1. By Country
    • 16.3.1.1. Australia
    • 16.3.1.2. New Zealand
  • 16.3.2. By Product Type
  • 16.3.3. By Material Type
  • 16.3.4. By End User
• 16.4. Market Attractiveness Analysis
  • 16.4.1. By Country
  • 16.4.2. By Product Type
  • 16.4.3. By Material Type
  • 16.4.4. By End User
• 16.5. Key Market Participants - Intensity Mapping
• 16.6. Drivers and Restraints - Impact Analysis

17. Middle East and Africa Bioabsorbable Stents Market Analysis 2019-2023 and Forecast 2024-2033

• 17.1. Introduction
• 17.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
• 17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2033
  • 17.3.1. By Country
    • 17.3.1.1. GCC Countries
    • 17.3.1.2. Turkey
    • 17.3.1.3. Northern Africa
    • 17.3.1.4. South Africa
    • 17.3.1.5. Rest of Middle East and Africa
  • 17.3.2. By Product Type
  • 17.3.3. By Material Type
  • 17.3.4. By End User
• 17.4. Market Attractiveness Analysis
  • 17.4.1. By Country
  • 17.4.2. By Product Type
  • 17.4.3. By Material Type
  • 17.4.4. By End User
• 17.5. Key Market Participants - Intensity Mapping
• 17.6. Drivers and Restraints - Impact Analysis

18. Emerging Countries Bioabsorbable Stents Market Analysis 2019-2023 and Forecast 2024-2033

• 18.1. Introduction
  • 18.1.1. Market Value Proportion Analysis, By Key Countries
  • 18.1.2. Global Vs. Country Growth Comparison
• 18.2. China Bioabsorbable Stents Market Analysis
  • 18.2.1. Introduction
  • 18.2.2. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy
    • 18.2.2.1. By Product Type
    • 18.2.2.2. By End User
    • 18.2.2.3. By Material Type
  • 18.2.3. China Bioabsorbable Implants Market - Competition Landscape
  • 18.2.4. China - Trade Analysis
• 18.3. Brazil Bioabsorbable Stents Market Analysis
  • 18.3.1. Introduction
  • 18.3.2. PESTLE Analysis
  • 18.3.3. Market and Value (US$ Mn) Analysis and Forecast by Market Taxonomy
    • 18.3.3.1. By Product Type
    • 18.3.3.2. By End User
    • 18.3.3.3. By Material Type
  • 18.3.4. Brazil Bioabsorbable Stents Market - Competition Landscape
• 18.4. Russia Bioabsorbable Stents Market Analysis
  • 18.4.1. Introduction
  • 18.4.2. PESTLE Analysis
    • 18.4.2.1. By Product Type
    • 18.4.2.2. By End User
    • 18.4.2.3. By Material Type
  • 18.4.3. Russia Bioabsorbable Stents Market - Competition Landscape

19. Market Structure Analysis

• 19.1. Market Analysis by Tier of Companies
• 19.2. Market Concentration
• 19.3. Market Share Analysis of Top Players
• 19.4. Market Presence Analysis
  • 19.4.1. Product foot print by Players
  • 19.4.2. Channel Foot Print by Players

20. Competition Analysis

• 20.1. Competition Dashboard
• 20.2. Pricing Analysis by Competition
• 20.3. Competition Benchmarking
• 20.4. Competition Deep Dive
  • 20.4.1. Boston Scientific Corporation
    • 20.4.1.1. Overview
    • 20.4.1.2. Product Portfolio
    • 20.4.1.3. Profitability by Market Segments (Product/Channel/Region)
    • 20.4.1.4. Sales Footprint
    • 20.4.1.5. Strategy Overview
      • 20.4.1.5.1. Marketing Strategy
      • 20.4.1.5.2. Product Strategy
  • 20.4.2. DENTSPLY Shiroma.
    • 20.4.2.1. Overview
    • 20.4.2.2. Product Portfolio
    • 20.4.2.3. Profitability by Market Segments (Product/Channel/Region)
    • 20.4.2.4. Sales Footprint
    • 20.4.2.5. Strategy Overview
      • 20.4.2.5.1. Marketing Strategy
      • 20.4.2.5.2. Product Strategy
  • 20.4.3. Meryl Life Sciences Pvt. Ltd.
    • 20.4.3.1. Overview
    • 20.4.3.2. Product Portfolio
    • 20.4.3.3. Profitability by Market Segments (Product/Channel/Region)
    • 20.4.3.4. Sales Footprint
    • 20.4.3.5. Strategy Overview
      • 20.4.3.5.1. Marketing Strategy
      • 20.4.3.5.2. Product Strategy
  • 20.4.4. Medtronic Plc
    • 20.4.4.1. Overview
    • 20.4.4.2. Product Portfolio
    • 20.4.4.3. Profitability by Market Segments (Product/Channel/Region)
    • 20.4.4.4. Sales Footprint
    • 20.4.4.5. Strategy Overview
      • 20.4.4.5.1. Marketing Strategy
      • 20.4.4.5.2. Product Strategy
  • 20.4.5. Smith & Nephew Plc
    • 20.4.5.1. Overview
    • 20.4.5.2. Product Portfolio
    • 20.4.5.3. Profitability by Market Segments (Product/Channel/Region)
    • 20.4.5.4. Sales Footprint
    • 20.4.5.5. Strategy Overview
      • 20.4.5.5.1. Marketing Strategy
      • 20.4.5.5.2. Product Strategy
  • 20.4.6. Stryker Corporation
    • 20.4.6.1. Overview
    • 20.4.6.2. Product Portfolio
    • 20.4.6.3. Profitability by Market Segments (Product/Channel/Region)
    • 20.4.6.4. Sales Footprint
    • 20.4.6.5. Strategy Overview
      • 20.4.6.5.1. Marketing Strategy
      • 20.4.6.5.2. Product Strategy
  • 20.4.7. Wright Medical Group
    • 20.4.7.1. Overview
    • 20.4.7.2. Product Portfolio
    • 20.4.7.3. Profitability by Market Segments (Product/Channel/Region)
    • 20.4.7.4. Sales Footprint
    • 20.4.7.5. Strategy Overview
      • 20.4.7.5.1. Marketing Strategy
      • 20.4.7.5.2. Product Strategy
  • 20.4.8. KLS Martin
    • 20.4.8.1. Overview
    • 20.4.8.2. Product Portfolio
    • 20.4.8.3. Profitability by Market Segments (Product/Channel/Region)
    • 20.4.8.4. Sales Footprint
    • 20.4.8.5. Strategy Overview
      • 20.4.8.5.1. Marketing Strategy
      • 20.4.8.5.2. Product Strategy
  • 20.4.9. BIOTRONIK Ltd
    • 20.4.9.1. Overview
    • 20.4.9.2. Product Portfolio
    • 20.4.9.3. Profitability by Market Segments (Product/Channel/Region)
    • 20.4.9.4. Sales Footprint
    • 20.4.9.5. Strategy Overview
      • 20.4.9.5.1. Marketing Strategy
      • 20.4.9.5.2. Product Strategy
  • 20.4.10. Syntellix AG
    • 20.4.10.1. Overview
    • 20.4.10.2. Product Portfolio
    • 20.4.10.3. Profitability by Market Segments (Product/Channel/Region)
    • 20.4.10.4. Sales Footprint
    • 20.4.10.5. Strategy Overview
      • 20.4.10.5.1. Marketing Strategy
      • 20.4.10.5.2. Product Strategy
  • 20.4.11. Q3 Medical Devices Limited.
    • 20.4.11.1. Overview
    • 20.4.11.2. Product Portfolio
    • 20.4.11.3. Profitability by Market Segments (Product/Channel/Region)
    • 20.4.11.4. Sales Footprint
    • 20.4.11.5. Strategy Overview
      • 20.4.11.5.1. Marketing Strategy
      • 20.4.11.5.2. Product Strategy
  • 20.4.12. JW Medical Systems LTD
    • 20.4.12.1. Overview
    • 20.4.12.2. Product Portfolio
    • 20.4.12.3. Profitability by Market Segments (Product/Channel/Region)
    • 20.4.12.4. Sales Footprint
    • 20.4.12.5. Strategy Overview
      • 20.4.12.5.1. Marketing Strategy
      • 20.4.12.5.2. Product Strategy
  • 20.4.13. ORBUSNEICH MEDICAL.
    • 20.4.13.1. Overview
    • 20.4.13.2. Product Portfolio
    • 20.4.13.3. Profitability by Market Segments (Product/Channel/Region)
    • 20.4.13.4. Sales Footprint
    • 20.4.13.5. Strategy Overview
      • 20.4.13.5.1. Marketing Strategy
      • 20.4.13.5.2. Product Strategy

21. Assumptions and Acronyms Used

22. Research Methodology